K.J. Harrison & Partners Inc Pfizer Inc Transaction History

K.J. Harrison & Partners Inc

$479 Million
Q1 2025

A detailed history of K.J. Harrison & Partners Inc transactions in Pfizer Inc stock. As of the latest transaction made, K.J. Harrison & Partners Inc holds 69,363 shares of PFE stock, worth $1.68 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

69,363

Previous 77,363 10.34%

Holding current value

$1.68 Million

Previous $2.05 Million 14.38%

% of portfolio

0.37%

Previous 0.35%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 24, 2025	SELL	$25.01 - $27.13 $200,080 - $217,040	-8,000 Reduced 10.34%	69,363 $1.76 Million
Q4 2024 Feb 04, 2025	SELL	$24.8 - $30.19 $1.26 Million - $1.54 Million	-50,900 Reduced 39.68%	77,363 $2.05 Million
Q3 2024 Oct 24, 2024	BUY	$27.7 - $31.39 $609,400 - $690,580	22,000 Added 20.7%	128,263 $3.71 Million
Q2 2024 Jul 26, 2024	SELL	$25.26 - $29.6 $263,967 - $309,320	-10,450 Reduced 8.95%	106,263 $2.97 Million
Q1 2024 Apr 26, 2024	BUY	$25.89 - $29.73 $1.94 Million - $2.23 Million	74,912 Added 179.21%	116,713 $3.24 Million
Q4 2023 Feb 02, 2024	BUY	$26.13 - $33.94 $129,395 - $168,070	4,952 Added 13.44%	41,801 $1.2 Million
Q3 2023 Oct 31, 2023	SELL	$32.09 - $37.51 $641,800 - $750,200	-20,000 Reduced 35.18%	36,849 $1.22 Million
Q2 2023 Jul 21, 2023	BUY	$36.12 - $41.79 $727,745 - $841,984	20,148 Added 54.9%	56,849 $2.09 Million
Q1 2023 Apr 24, 2023	SELL	$39.39 - $51.28 $709,020 - $923,040	-18,000 Reduced 32.91%	36,701 $1.5 Million
Q4 2022 Jan 25, 2023	BUY	$41.75 - $54.5 $751,500 - $981,000	18,000 Added 49.04%	54,701 $0
Q3 2022 Oct 21, 2022	SELL	$43.76 - $53.42 $874,499 - $1.07 Million	-19,984 Reduced 35.25%	36,701 $1.61 Million
Q2 2022 Jul 27, 2022	SELL	$46.53 - $55.17 $465,300 - $551,700	-10,000 Reduced 15.0%	56,685 $2.98 Million
Q1 2022 Apr 21, 2022	BUY	$45.75 - $56.69 $1.55 Million - $1.92 Million	33,829 Added 102.96%	66,685 $3.45 Million
Q4 2021 Jan 26, 2022	SELL	$41.32 - $61.25 $102,267 - $151,593	-2,475 Reduced 7.01%	32,856 $1.94 Million
Q3 2021 Nov 05, 2021	SELL	$39.25 - $50.42 $902,750 - $1.16 Million	-23,000 Reduced 39.43%	35,331 $1.53 Million
Q2 2021 Aug 04, 2021	BUY	$35.91 - $40.68 $1.07 Million - $1.21 Million	29,666 Added 103.49%	58,331 $2.29 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $167,450 - $188,850	5,000 Added 21.13%	28,665 $1.04 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $21,420 - $27,238	-640 Reduced 2.63%	23,665 $871,000
Q2 2020 Aug 03, 2020	BUY	$30.12 - $36.54 $24,849 - $30,145	825 Added 3.51%	24,305 $795,000
Q4 2019 Jan 27, 2020	SELL	$32.92 - $37.36 $450,345 - $511,084	-13,680 Reduced 36.81%	23,480 $920,000
Q3 2019 Oct 25, 2019	BUY	$32.49 - $42.13 $444,463 - $576,338	13,680 Added 58.26%	37,160 $1.34 Million
Q1 2019 Apr 26, 2019	SELL	$37.5 - $41.2 $7,125 - $7,828	-190 Reduced 0.8%	23,480 $997,000
Q4 2018 Jan 24, 2019	BUY	$38.47 - $43.86 $7,309 - $8,333	190 Added 0.81%	23,670 $1.03 Million
Q3 2017 Oct 27, 2017	BUY	$31.0 - $34.15 $727,880 - $801,842	23,480	23,480 $838,000

Others Institutions Holding PFE

# of Institutions

3,371

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $136B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on K.J. Harrison & Partners Inc with notifications on news.

Account

K.J. Harrison & Partners Inc Pfizer Inc Transaction History